Dr. Dijana Bovan

Dijana Bovan completed her undergraduate studies at the Faculty of Biology, University of Belgrade in 2013 and obtained the title of graduate molecular biologist and physiologist. She enrolled in doctoral studies at the Faculty of Biology of the University of Belgrade in 2013, on the Molecular Oncology module. Since January 2015, she has been employed in the Department of Immunology at the Institute for Biological Research "Siniša Stanković" - an Institute of national importance for the Republic of Serbia. In September 2017, she was elected to the position of research assistant. She defended her doctoral dissertation entitled "Molecular mechanisms of the action of antitumor agent from the synthetic tubulysins’ group, tubugi 1, on selected melanoma model systems" in October 2020 and in 2021 she received "Stanka Romac" award for the best doctoral thesis in the field of Human Molecular Genetics or Biomedicine. In February 2021, she received the title of research associate. As part of the bilateral scientific-technological cooperation project between the Republic of Serbia and the Federal Republic of Germany, Dijana Bovan spent a month at the Leibniz Institute for Plant Biochemistry in Halle on three occasions (2015, 2016 and 2017), and 25 days in 2018. in Leipzig, Germany within the Erasmus + program. In addition, she was a participant in the National Project (2019), a bilateral project with China (2018-2021), as well as two projects sponsored by Zepter International for the period (2019-2020 and 2020-2021). He is currently a participant in the project of the Science Fund of the Republic of Serbia from the Prism program (ADVANCED). She is an active member of the Serbian Society of Cancer Researchers (SDIR), the European Association for Cancer Research (EARC), the Serbian Society for Molecular Biology (MolBioS), the Club of Young Immunologists of Serbia (KMIS), the Young European Federation of Immunological Societies (yEFIS), the Biochemical Society of Serbia (BDS). Her research interests are experimental oncology and immuno-oncology.